Elnas, Emelda S.

HRN: 17-08-18  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/11/2023
CEFUROXIME 1.5GM (VIAL)
05/11/2023
05/18/2023
IV
1.5GMS
Prior OR
Cholelithiasis
Waiting Final Action 
05/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/11/2023
05/18/2023
IV
500 MG
Prior OR
Cholelithiasis
Waiting Final Action 
05/12/2023
CEFUROXIME 750MG (VIAL)
05/12/2023
05/17/2023
IV
1.5g
Q8
S/p Cholecystectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: